{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:45:31Z","timestamp":1794573931026,"version":"4.9.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-69796-0","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:15:09Z","timestamp":1772169309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["NR2F6 deletion revives CAR-T cell function and induces antigen-agnostic immune memory in solid tumors"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2167-9346","authenticated-orcid":false,"given":"Dominik","family":"Humer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4146-4664","authenticated-orcid":false,"given":"Victoria","family":"Klepsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1754-690X","authenticated-orcid":false,"given":"Dietmar","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"H\u00f6lzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0904-0968","authenticated-orcid":false,"given":"Ji\u0159\u00ed","family":"Koutn\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tajana","family":"Sajinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viana","family":"Wille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"F\u00fcrst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Savic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8737-005X","authenticated-orcid":false,"given":"Gabriel","family":"Diem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8955-7654","authenticated-orcid":false,"given":"Wilfried","family":"Posch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira-Ida","family":"Skvortsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Krogsdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2265-1974","authenticated-orcid":false,"given":"Sieghart","family":"Sopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5612-4673","authenticated-orcid":false,"given":"Sebastian","family":"Kobold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0636-7351","authenticated-orcid":false,"given":"Zlatko","family":"Trajanoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Thuille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4761-075X","authenticated-orcid":false,"given":"Dominik","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2085-8325","authenticated-orcid":false,"given":"Gottfried","family":"Baier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"69796_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41586-023-05707-3","volume":"614","author":"L Labanieh","year":"2023","unstructured":"Labanieh, L. & Mackall, C. L. CAR immune cells: design principles, resistance and the next generation. Nature 614, 635\u2013648 (2023).","journal-title":"Nature"},{"key":"69796_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41551-018-0235-9","volume":"2","author":"L Labanieh","year":"2018","unstructured":"Labanieh, L., Majzner, R. G. & Mackall, C. L. Programming CAR-T cells to kill cancer. Nat. Biomed. Eng. 2, 377\u2013391 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"69796_CR3","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude, S. L. et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med 371, 1507\u20131517 (2014).","journal-title":"N. Engl. J. Med"},{"key":"69796_CR4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa2116133","volume":"386","author":"FL Locke","year":"2022","unstructured":"Locke, F. L. et al. Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma. N. Engl. J. Med 386, 640\u2013654 (2022).","journal-title":"N. Engl. J. Med"},{"key":"69796_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa1709919","volume":"378","author":"JH Park","year":"2018","unstructured":"Park, J. H. et al. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N. Engl. J. Med 378, 449\u2013459 (2018).","journal-title":"N. Engl. J. Med"},{"key":"69796_CR6","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1158\/2159-8290.CD-15-1020","volume":"5","author":"E Sotillo","year":"2015","unstructured":"Sotillo, E. et al. Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy. Cancer Discov. 5, 1282\u20131295 (2015).","journal-title":"Cancer Discov."},{"key":"69796_CR7","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/s41591-018-0146-z","volume":"24","author":"EJ Orlando","year":"2018","unstructured":"Orlando, E. J. et al. Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia. Nat. Med 24, 1504\u20131506 (2018).","journal-title":"Nat. Med"},{"key":"69796_CR8","doi-asserted-by":"publisher","first-page":"eaaa0984","DOI":"10.1126\/scitranslmed.aaa0984","volume":"9","author":"DM O\u2019Rourke","year":"2017","unstructured":"O\u2019Rourke, D. M. et al. A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Sci. Transl. Med 9, eaaa0984 (2017).","journal-title":"Sci. Transl. Med"},{"key":"69796_CR9","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s43018-021-00244-2","volume":"2","author":"K Hirabayashi","year":"2021","unstructured":"Hirabayashi, K. et al. Dual targeting CAR-T cells with optimal costimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors. Nat. Cancer 2, 904\u2013918 (2021).","journal-title":"Nat. Cancer"},{"key":"69796_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-024-07242-1","volume":"629","author":"JD Chan","year":"2024","unstructured":"Chan, J. D. et al. FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature 629, 201\u2013210 (2024).","journal-title":"Nature"},{"key":"69796_CR11","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.ymthe.2024.05.006","volume":"32","author":"Y Shi","year":"2024","unstructured":"Shi, Y. et al. GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy. Mol. Ther. 32, 2393\u20132405 (2024).","journal-title":"Mol. Ther."},{"key":"69796_CR12","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1016\/j.cell.2023.06.002","volume":"186","author":"L Ma","year":"2023","unstructured":"Ma, L. et al. Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity. Cell 186, 3148\u20133165 e3120 (2023).","journal-title":"Cell"},{"key":"69796_CR13","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1158\/1078-0432.CCR-20-0305","volume":"26","author":"P Brossart","year":"2020","unstructured":"Brossart, P. The role of antigen spreading in the efficacy of immunotherapies. Clin. Cancer Res 26, 4442\u20134447 (2020).","journal-title":"Clin. Cancer Res"},{"key":"69796_CR14","doi-asserted-by":"publisher","first-page":"254ra128","DOI":"10.1126\/scitranslmed.3008918","volume":"6","author":"P Kvistborg","year":"2014","unstructured":"Kvistborg, P. et al. Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response. Sci. Transl. Med 6, 254ra128 (2014).","journal-title":"Sci. Transl. Med"},{"key":"69796_CR15","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.ccell.2022.08.003","volume":"40","author":"MM Awad","year":"2022","unstructured":"Awad, M. M. et al. Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer. Cancer Cell 40, 1010\u20131026 e1011 (2022).","journal-title":"Cancer Cell"},{"key":"69796_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ccell.2019.02.006","volume":"35","author":"NF Kuhn","year":"2019","unstructured":"Kuhn, N. F. et al. CD40 ligand-modified chimeric antigen receptor t cells enhance antitumor function by eliciting an endogenous antitumor response. Cancer Cell 35, 473\u2013488.e476 (2019).","journal-title":"Cancer Cell"},{"key":"69796_CR17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41590-020-0676-7","volume":"21","author":"J Lai","year":"2020","unstructured":"Lai, J. et al. Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity. Nat. Immunol. 21, 914\u2013926 (2020).","journal-title":"Nat. Immunol."},{"key":"69796_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.omto.2020.07.005","volume":"18","author":"A Klampatsa","year":"2020","unstructured":"Klampatsa, A. et al. Analysis and augmentation of the immunologic bystander effects of CAR T cell therapy in a syngeneic mouse cancer model. Mol. Ther. Oncol. 18, 360\u2013371 (2020).","journal-title":"Mol. Ther. Oncol."},{"key":"69796_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.immuni.2008.06.008","volume":"29","author":"N Hermann-Kleiter","year":"2008","unstructured":"Hermann-Kleiter, N. et al. The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity. Immunity 29, 205\u2013216 (2008).","journal-title":"Immunity"},{"key":"69796_CR20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jaut.2012.07.007","volume":"39","author":"N Hermann-Kleiter","year":"2012","unstructured":"Hermann-Kleiter, N. et al. Nuclear orphan receptor NR2F6 directly antagonizes NFAT and RORgammat binding to the Il17a promoter. J. Autoimmun. 39, 428\u2013440 (2012).","journal-title":"J. Autoimmun."},{"key":"69796_CR21","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.celrep.2015.08.035","volume":"12","author":"N Hermann-Kleiter","year":"2015","unstructured":"Hermann-Kleiter, N. et al. The nuclear orphan receptor NR2F6 is a central checkpoint for cancer immune surveillance. Cell Rep. 12, 2072\u20132085 (2015).","journal-title":"Cell Rep."},{"key":"69796_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07407-4","volume":"16","author":"J Woelk","year":"2025","unstructured":"Woelk, J. et al. Regulation of NK cell development, maturation, and antitumor responses by the nuclear receptor NR2F6. Cell Death Dis. 16, 77 (2025).","journal-title":"Cell Death Dis."},{"key":"69796_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03470-9","volume":"12","author":"B Jakic","year":"2021","unstructured":"Jakic, B. et al. Loss of the orphan nuclear receptor NR2F6 enhances CD8(+) T-cell memory via IFN-gamma. Cell Death Dis. 12, 187 (2021).","journal-title":"Cell Death Dis."},{"key":"69796_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04004-2","volume":"9","author":"V Klepsch","year":"2018","unstructured":"Klepsch, V. et al. Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1\/PD-1 cancer immune checkpoint blockade. Nat. Commun. 9, 1538 (2018).","journal-title":"Nat. Commun."},{"key":"69796_CR25","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1136\/gutjnl-2016-313466","volume":"67","author":"V Klepsch","year":"2018","unstructured":"Klepsch, V. et al. Nuclear orphan receptor NR2F6 as a safeguard against experimental murine colitis. Gut 67, 1434\u20131444 (2018).","journal-title":"Gut"},{"key":"69796_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf6621","volume":"9","author":"H Kim","year":"2023","unstructured":"Kim, H. et al. Melanoma-intrinsic NR2F6 activity regulates antitumor immunity. Sci. Adv. 9, eadf6621 (2023).","journal-title":"Sci. Adv."},{"key":"69796_CR27","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.1158\/1078-0432.CCR-18-3927","volume":"25","author":"CH Karches","year":"2019","unstructured":"Karches, C. H. et al. Bispecific antibodies enable synthetic agonistic receptor-transduced T cells for tumor immunotherapy. Clin. Cancer Res 25, 5890\u20135900 (2019).","journal-title":"Clin. Cancer Res"},{"key":"69796_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","volume":"602","author":"JJ Melenhorst","year":"2022","unstructured":"Melenhorst, J. J. et al. Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells. Nature 602, 503\u2013509 (2022).","journal-title":"Nature"},{"key":"69796_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.omto.2023.04.003","volume":"29","author":"L Shiqi","year":"2023","unstructured":"Shiqi, L. et al. Durable remission related to CAR-T persistence in R\/R B-ALL and long-term persistence potential of prime CAR-T. Mol. Ther. Oncolytics 29, 107\u2013117 (2023).","journal-title":"Mol. Ther. Oncolytics"},{"key":"69796_CR30","doi-asserted-by":"publisher","first-page":"eabb9726","DOI":"10.1126\/sciimmunol.abb9726","volume":"5","author":"G Escobar","year":"2020","unstructured":"Escobar, G., Mangani, D. & Anderson, A. C. T cell factor 1: a master regulator of the T cell response in disease. Sci. Immunol. 5, eabb9726 (2020).","journal-title":"Sci. Immunol."},{"key":"69796_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","volume":"45","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections. Immunity 45, 415\u2013427 (2016).","journal-title":"Immunity"},{"key":"69796_CR32","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2021.06.012","volume":"39","author":"GM Delgoffe","year":"2021","unstructured":"Delgoffe, G. M. et al. The role of exhaustion in CAR T cell therapy. Cancer Cell 39, 885\u2013888 (2021).","journal-title":"Cancer Cell"},{"key":"69796_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nm.3838","volume":"21","author":"AH Long","year":"2015","unstructured":"Long, A. H. et al. 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat. Med 21, 581\u2013590 (2015).","journal-title":"Nat. Med"},{"key":"69796_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","volume":"579","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature 579, 415\u2013420 (2020).","journal-title":"Nature"},{"key":"69796_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06382-y","volume":"14","author":"Y Hu","year":"2023","unstructured":"Hu, Y. et al. The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles. Cell Death Dis. 14, 836 (2023).","journal-title":"Cell Death Dis."},{"key":"69796_CR36","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41590-020-0760-z","volume":"21","author":"DT Utzschneider","year":"2020","unstructured":"Utzschneider, D. T. et al. Early precursor T cells establish and propagate T cell exhaustion in chronic infection. Nat. Immunol. 21, 1256\u20131266 (2020).","journal-title":"Nat. Immunol."},{"key":"69796_CR37","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.1164206","volume":"322","author":"K Hildner","year":"2008","unstructured":"Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097\u20131100 (2008).","journal-title":"Science"},{"key":"69796_CR38","doi-asserted-by":"publisher","first-page":"e122857","DOI":"10.1172\/jci.insight.122857","volume":"3","author":"HL Kinkead","year":"2018","unstructured":"Kinkead, H. L. et al. Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer. JCI Insight 3, e122857 (2018).","journal-title":"JCI Insight"},{"key":"69796_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59904-x","volume":"16","author":"G Cheloni","year":"2025","unstructured":"Cheloni, G. et al. Durable response to CAR T is associated with elevated activation and clonotypic expansion of the cytotoxic native T cell repertoire. Nat. Commun. 16, 4819 (2025).","journal-title":"Nat. Commun."},{"key":"69796_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner, R. C. & Sterner, R. M. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021).","journal-title":"Blood Cancer J."},{"key":"69796_CR41","doi-asserted-by":"publisher","first-page":"e010581","DOI":"10.1136\/jitc-2024-010581","volume":"13","author":"XN Li","year":"2025","unstructured":"Li, X. N. et al. XCL1-secreting CEA CAR-T cells enhance endogenous CD8(+) T cell responses to tumor neoantigens to confer a long-term antitumor immunity. J. Immunother. Cancer 13, e010581 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"69796_CR42","doi-asserted-by":"publisher","first-page":"e009994","DOI":"10.1136\/jitc-2024-009994","volume":"13","author":"AO Mohamed","year":"2025","unstructured":"Mohamed, A. O. et al. CD4 T cell depletion increases memory differentiation of endogenous and CAR T cells and enhances the efficacy of Super2 and IL-33-armored CAR T cells against solid tumors. J. Immunother. Cancer 13, e009994 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"69796_CR43","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E. J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"69796_CR44","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.immuni.2018.04.026","volume":"48","author":"B Bengsch","year":"2018","unstructured":"Bengsch, B. et al. Epigenomic-guided mass cytometry profiling reveals disease-specific features of exhausted CD8 T cells. Immunity 48, 1029\u20131045.e1025 (2018).","journal-title":"Immunity"},{"key":"69796_CR45","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","volume":"24","author":"X Guo","year":"2018","unstructured":"Guo, X. et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat. Med 24, 978\u2013985 (2018).","journal-title":"Nat. Med"},{"key":"69796_CR46","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller, B. C. et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326\u2013336 (2019).","journal-title":"Nat. Immunol."},{"key":"69796_CR47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui, I. et al. Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195\u2013211.e110 (2019).","journal-title":"Immunity"},{"key":"69796_CR48","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","volume":"175","author":"M Sade-Feldman","year":"2018","unstructured":"Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998\u20131013.e1020 (2018).","journal-title":"Cell"},{"key":"69796_CR49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","volume":"45","author":"B Bengsch","year":"2016","unstructured":"Bengsch, B. et al. Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion. Immunity 45, 358\u2013373 (2016).","journal-title":"Immunity"},{"key":"69796_CR50","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","volume":"21","author":"YR Yu","year":"2020","unstructured":"Yu, Y. R. et al. Disturbed mitochondrial dynamics in CD8(+) TILs reinforce T cell exhaustion. Nat. Immunol. 21, 1540\u20131551 (2020).","journal-title":"Nat. Immunol."},{"key":"69796_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","volume":"22","author":"NE Scharping","year":"2021","unstructured":"Scharping, N. E. et al. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat. Immunol. 22, 205\u2013215 (2021).","journal-title":"Nat. Immunol."},{"key":"69796_CR52","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41590-020-0725-2","volume":"21","author":"SA Vardhana","year":"2020","unstructured":"Vardhana, S. A. et al. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nat. Immunol. 21, 1022\u20131033 (2020).","journal-title":"Nat. Immunol."},{"key":"69796_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29026-9","volume":"13","author":"F Nikolos","year":"2022","unstructured":"Nikolos, F. et al. Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors. Nat. Commun. 13, 1487 (2022).","journal-title":"Nat. Commun."},{"key":"69796_CR54","doi-asserted-by":"crossref","unstructured":"Wang-Bishop, L. et al. Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma. J. Immunother. Cancer 8, e000282 (2020).","DOI":"10.1136\/jitc-2019-000282"},{"key":"69796_CR55","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1101\/gad.317905","volume":"19","author":"M Warnecke","year":"2005","unstructured":"Warnecke, M., Oster, H., Revelli, J. P., Alvarez-Bolado, G. & Eichele, G. Abnormal development of the locus coeruleus in Ear2(Nr2f6)-deficient mice impairs the functionality of the forebrain clock and affects nociception. Genes Dev. 19, 614\u2013625 (2005).","journal-title":"Genes Dev."},{"key":"69796_CR56","doi-asserted-by":"crossref","unstructured":"Cadilha, B. L. et al. Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumors. Sci Adv 7, eabi5781 (2021).","DOI":"10.1126\/sciadv.abi5781"},{"key":"69796_CR57","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41551-021-00737-6","volume":"5","author":"S Lesch","year":"2021","unstructured":"Lesch, S. et al. T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours. Nat. Biomed. Eng. 5, 1246\u20131260 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"69796_CR58","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.immuni.2022.12.010","volume":"56","author":"D Briukhovetska","year":"2023","unstructured":"Briukhovetska, D. et al. T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis. Immunity 56, 143\u2013161.e111 (2023).","journal-title":"Immunity"},{"key":"69796_CR59","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman, E. K., Chen, T., Amendola, M. & van Steensel, B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res 42, e168 (2014).","journal-title":"Nucleic Acids Res"},{"key":"69796_CR60","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/icb.2011.11","volume":"90","author":"C Lutz-Nicoladoni","year":"2012","unstructured":"Lutz-Nicoladoni, C. et al. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine. Immunol. Cell Biol. 90, 130\u2013134 (2012).","journal-title":"Immunol. Cell Biol."},{"key":"69796_CR61","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels, P. A. et al. The nf-core framework for community-curated bioinformatics pipelines. Nat. Biotechnol. 38, 276\u2013278 (2020).","journal-title":"Nat. Biotechnol."},{"key":"69796_CR62","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"69796_CR63","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nmeth.3885","volume":"13","author":"N Ignatiadis","year":"2016","unstructured":"Ignatiadis, N., Klaus, B., Zaugg, J. B. & Huber, W. Data-driven hypothesis weighting increases detection power in genome-scale multiple testing. Nat. Methods 13, 577\u2013580 (2016).","journal-title":"Nat. Methods"},{"key":"69796_CR64","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/bioinformatics\/btl140","volume":"22","author":"A Alexa","year":"2006","unstructured":"Alexa, A., Rahnenfuhrer, J. & Lengauer, T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22, 1600\u20131607 (2006).","journal-title":"Bioinformatics"},{"key":"69796_CR65","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"69796_CR66","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41587-023-01733-8","volume":"41","author":"I Virshup","year":"2023","unstructured":"Virshup, I. et al. The scverse project provides a computational ecosystem for single-cell omics data analysis. Nat. Biotechnol. 41, 604\u2013606 (2023).","journal-title":"Nat. Biotechnol."},{"key":"69796_CR67","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41587-021-01206-w","volume":"40","author":"A Gayoso","year":"2022","unstructured":"Gayoso, A. et al. A Python library for probabilistic analysis of single-cell omics data. Nat. Biotechnol. 40, 163\u2013166 (2022).","journal-title":"Nat. Biotechnol."},{"key":"69796_CR68","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cels.2020.05.010","volume":"11","author":"NJ Bernstein","year":"2020","unstructured":"Bernstein, N. J. et al. Solo: doublet identification in single-cell RNA-seq via semi-supervised deep learning. Cell Syst. 11, 95\u2013101.e105 (2020).","journal-title":"Cell Syst."},{"key":"69796_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"69796_CR70","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/hpb.12334","volume":"17","author":"KM Bever","year":"2015","unstructured":"Bever, K. M. et al. The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy. HPB (Oxf.) 17, 292\u2013298 (2015).","journal-title":"HPB (Oxf.)"},{"key":"69796_CR71","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1093\/bioinformatics\/btaa611","volume":"36","author":"G Sturm","year":"2020","unstructured":"Sturm, G. et al. Scirpy: a Scanpy extension for analyzing single-cell T-cell receptor-sequencing data. Bioinformatics 36, 4817\u20134818 (2020).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69796-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T22:01:49Z","timestamp":1775772109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69796-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69796"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69796-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SK has received honoraria from Cymab, Plectonic, TCR2 Inc., Miltenyi, Galapagos, Novartis, BMS and GSK. SK is an inventor of several patents in the field of immuno-oncology. SK received license fees from TCR2 Inc and Carina Biotech. SK received research support from TCR2 Inc., Tabby Therapeutics, Catalym GmBH, Plectonic GmBH and Arcus Bioscience for work unrelated to the manuscript. V.K., J.K., K.S., D.H. and G.B. are inventors on patents related to immunological targets in the field of immuno-oncology. D.R., I.H., D.S., V.L., S.P., T.S., Z.S., V.W., A.F., G.D., W.P., I-I. S., A.K., S.S., Z.T. and T.G. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3264"}}